Development and evaluation of rectal suppository formulation for antidiabetic activity of repaglinide: A comparative study
Letters in Drug Design & Discovery · 2026-02 · 23 (2) · 100392
DOI: 10.1016/j.lddd.2026.100392 ↗Kurz gefasst
Fachartikel in der Zeitschrift Letters in Drug Design & Discovery, 2026-02. Verfasst von Asiya Asal Khan und 7 weiteren Autor:innen. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Khan, A. A., Baseer, A., Ullah, K. H., Badshah, M., Rahim, A., Khan, J. Z., Khan, J., & Iqbal, H. (2026). Development and evaluation of rectal suppository formulation for antidiabetic activity of repaglinide: A comparative study. Letters in Drug Design & Discovery, 23(2), 100392. https://doi.org/10.1016/j.lddd.2026.100392
Vancouver
Khan AA, Baseer A, Ullah KH, Badshah M, Rahim A, Khan JZ, et al. Development and evaluation of rectal suppository formulation for antidiabetic activity of repaglinide: A comparative study. Letters in Drug Design & Discovery. 2026;23(2):100392. doi:10.1016/j.lddd.2026.100392
BibTeX
@article{Khan2026,
author = {Khan, Asiya Asal and Baseer, Abdul and Ullah, Kamran Hidayat and Badshah, Munair and Rahim, Abdur and Khan, Jehan Zeb and Khan, Jawad and Iqbal, Hamid},
title = {Development and evaluation of rectal suppository formulation for antidiabetic activity of repaglinide: A comparative study},
journal = {Letters in Drug Design & Discovery},
year = {2026},
volume = {23},
number = {2},
pages = {100392},
doi = {10.1016/j.lddd.2026.100392}
}
EUVIMED